Joint Management setup at Klinik Permanence - Press release
PDF | 118.09 KB
Daniel Freiburghaus, Hospital Manager of Hirslanden Klinik Permanence in Bern, will hand over management of the hospital to Dr. Julia Beel and Claudine Jungo on 1 October 2020. Thus two women are taking the helm who have already proven their expertise within the Hirslanden Group.
Hirslanden hospitals are seeing a switch-over: Dr. Julia Beel and Claudine Jungo, who presently serve ad interim as managers of Hirslanden Campus Bern and accordingly are responsible for Klinik Beau-Site and Salem-Spital, will take on the management of Klinik Permanence.
As announced in the press release on 4 October 2019, Daniel Lüscher will take on management of Hirslanden Campus Bern this spring. He will duly start his assignment on 1 March 2020. Dr Julia Beel and Claudine Jungo will remain on the Bern campus from March to the end of September 2020 and will serve as deputies to the new Hospital Manager. They will retain this position even after commencing their new role as Hospital Co-Managers of Klinik Permanence on 1 October 2020.
"I am extremely pleased that we have been able to recruit two women to head Klinik Permanence who already know Hirslanden very well. This will ensure continuity for the hospitals and for Bern as a location. This example also shows that we are consistently pursuing our chosen course within the Hirslanden Group in order to establish flexible forms of work such as job sharing even in management positions," says Stéphan Studer, COO West of the Hirslanden Private Hospital Group.
Claudine Jungo started her professional career as a nurse. After a postgraduate degree in quality management at Hirslanden, she worked as head of the Quality and Development department at the Hirslanden hospitals in Bern. After a two-year EMBA programme, she moved to South Africa to join the parent company Mediclinic at its headquarters in Stellenbosch and returned to Klinik Permanence in 2015 as Head of Nursing and Corporate Development.
Before becoming self-employed as a consultant, Dr. Julia Beel served as Head of Clinical Services and as a member of the executive management at the Hirslanden Klinik Beau-Site from 2012 to 2016. She completed her medical studies at the University of Bern in 2004 and subsequently worked in various project management functions in the medical field.
Daniel Freiburghaus, the current Hospital Manager of Klinik Permanence, will act as advisor to the new Bernese leadership trio from 1 October 2020, before retiring on 31 March 2021. He has been working at Hirslanden since 2010; first he served as Hospital Manager of the Salem Hospital and Klinik Permanence, since 2013 he has been the Hospital Manager of Klinik Permanence. Under his leadership, Klinik Permanence has continued to strengthen its position as a first-class provider of medical care specialising in the musculoskeletal system and sports medicine. He also pushed ahead with the expansion of extended primary care with a 24-hour emergency ward and general surgery. Together with the Hirslanden Campus Bern Salem-Spital / Klinik Beau-Site and Klinik Linde in Biel, Klinik Permanence will thus play a key role in the provision of healthcare to the regional population.
The Executive Committee would like to thank Daniel Freiburghaus for his many years of dedicated service and wishes him all the best for his forthcoming retirement.
The Hirslanden Private Hospital Group consists of 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 2 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. The Group has 2,303 affiliated doctors and 10,442 employees, of whom 510 are permanently employed doctors. Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2018/19 financial year, the Group generated turnover of CHF 1,778 million. As at 31 March 2019, the Group had treated 106,851 patients, amounting to a total of 479,631 inpatient days. In insurance terms, the patient mix consists of 48.7% basic, 29.5% semi-private, and 21.8% privately insured patients.
The Hirslanden Private Hospital Group is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, Hirslanden stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Private Hospital Group was formed in 1990 through the merger of several Swiss private hospitals. Since 2007 it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.